NEWRON PHARMACEUTICALS S.P.A. EUR0.20 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QOI for the last semiannual is 3.28 M CHF, and it's 3.98% lower compared to the previous semiannual. The net income of H1 24 is -9.19 M CHF.